ARCHIVES

Imbruvica Improves PFS, OS In Phase III CLL Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

Research Needed To Improve Survival In Adolescents, Young Adults With Cancer

January 26, 2007

NIH Limits Increases In Competing Renewals To Biomedical Deflator

August 30, 1991

Max Wicha Describes Michigan’s Restructuring Planning For Growth

May 7, 1999

Lombardi Center, Virgin Islands Collaborate On Patient Care

August 7, 1981

NCI Study Finds No Greater Cancer Risk Near Nuclear Plants

September 28, 1990